OWCP — OWC Pharmaceutical Research Cashflow Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $0.00m
- -$1.46m
Annual cashflow statement for OWC Pharmaceutical Research, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2014 December 31st | 2015 December 31st | 2016 December 31st | 2017 December 31st | 2018 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -5.07 | -1.65 | -2.29 | -4.56 | -10.3 |
Depreciation | |||||
Non-Cash Items | 4.46 | 0.374 | 1.67 | 3.3 | 7.56 |
Other Non-Cash Items | |||||
Changes in Working Capital | 0.007 | 0.055 | 0.082 | 0.06 | 0.19 |
Change in Accounts Receivable | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | -0.602 | -1.22 | -0.529 | -1.19 | -2.5 |
Capital Expenditures | -0.032 | -0.003 | -0.002 | -0.01 | -0.028 |
Purchase of Fixed Assets | |||||
Cash from Investing Activities | -0.032 | -0.003 | -0.002 | -0.01 | -0.028 |
Financing Cash Flow Items | 0.028 | 0 | — | 0.051 | 0.105 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 2.09 | 0.124 | 0.646 | 1.69 | 5.02 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 1.47 | -1.11 | 0.115 | 0.498 | 2.49 |